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Abstract
Background: The generation of antibodies is impaired in newborns due to an immature immune system and reduced
exposure to pathogens due to maternally derived antibodies and placental functions. During nursing, the immune system
of newborns is challenged with multiple milk-derived proteins. Amongst them, caseins are the main constituent. In
particular, human aS1-casein (CSN1S1) was recently shown to possess immunomodulatory properties. We were thus
interested to determine if auto-antibodies to CSN1S1 are induced by breast-feeding and may be sustained into adulthood.
Methods: 62 sera of healthy adult individuals who were (n = 37) or were not (n = 25) breast-fed against human CSN1S1 were
investigated by a new SD (surface display)-ELISA. For cross-checking, these sera were tested for anti Epstein-Barr virus (EBV)
antibodies by a commercial ELISA.
Results: IgG-antibodies were predominantly detected in individuals who had been nursed. At a cut-off value of 0.4, the SD-
ELISA identified individuals with a history of having been breast-fed with a sensitivity of 80% and a specificity of 92%. Under
these conditions, 35 out of 37 sera from healthy donors, who where breast-fed, reacted positively but only 5 sera of the 25
donors who were not breast-fed. The duration of breast-feeding was of no consequence to the antibody reaction as some
healthy donors were only short term breast-fed (5 days minimum until 6 weeks maximum), but exhibited significant serum
reaction against human CSN1S1 nonetheless.
Conclusion: We postulate that human CSN1S1 is an autoantigen. The antigenicity is orally determined, caused by breast-
feeding, and sustained into adulthood.
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Introduction
The healthy human fetus is generally considered not to be
significantly engaged in specific immunoglobulin production [1,2].
Protection from pathogens in utero are conveyed by the placental
barrier and transfer of protective antibodies of the mother [3,4]. In
contrast, infections in utero or immediately post partum as well as
vaccinations can prompt specific antibody production against
pathogens in neonates [1,5,6]. In the absence of foreign antigens in
the fetus, self proteins may serve as an antigenic stimulus [7],
creating antibodies that may be mono- or polyspecific and directed
against self-tissue components [7,8]. Although their precise role is
currently unknown, it is speculated that these autoantibodies may
confer protection against foreign pathogens [8] or help to survey
the state of the individual’s own cells [7,9]. Illnesses induced by
these early formed autoantibodies are only rarely observed [10].
Interestingly, these autoantibodies are not equally present in adults
[7,8], suggesting that autoreactive B-cells are mostly eliminated in
the healthy maturing immune system.
Milk contains numerous proteins exposed to the immune system
of neonates during nursing. Caseins are the main milk proteins of
almost all mammalian species [11,12]. They are a heterogeneous
group of phosphoproteins, forming micelles with calcium phos-
phate and other components. The main biological function of
caseins is to provide the progeny with a source of phosphate and
calcium for the mineralization process of calcified tissues as well as
amino acids [13]. In the course of natural evolution, some proteins
are known to take up tasks besides their supposed initial
functionality, a process known as protein promiscuity [14]. In
recent years, evidence accumulated that caseins are such proteins:
multiple immunomodulatory functions including modulations of
the innate immune response of intestinal cells have been described.
Recent research unveiled that human aS1-casein (CSN1S1)
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possesses immunomodulatory properties. Human CSN1S1 is
expressed in monocytes and stimulates the expression of proin-
flammatory cytokines e.g. GM-CSF [15].
The current study aimed to investigate if a protein exposed to
the immune system during nursing can generate a persistent
antibody reaction and focused on the above described multifunc-
tional, milk-derived protein CSN1S1. For this purpose, serum of
62 healthy volunteers who were or were not breast-fed was
assessed for CSN1S1 antibodies using a SD-ELISA based on E. coli
displaying the protein, similar to a strategy that was established
before for human autoantigen Ro/SS-A [16]. It turned out that a
history of having been breast-fed was strongly associated to an
IgG-antibody reaction against CSN1S1, whereas a negative
reaction stood into relation with formula feeding. (i.e. no exposure
to human milk-proteins).
Materials and Methods
Human sera
62 human sera from healthy donors were obtained by puncture
of the antecubital vein. Donors, who had been selected randomly,
were free of medication and consisted of 43 female and 19 male
persons of an age ranging from 22–73. All sera were stored at
220uC prior to the assay. All donors gave their full informed
consent and the study was approved by the local ethics committee
(Ethikkommission der Medizinischen Fakulta¨t der Heinrich-
Heine-Universita¨t, Moorenstr. 5, D-40225 Du¨sseldorf).
Materials
Goat anti-human IgG conjugated with horseradish peroxidase
was obtained from Beckman Coulter (Krefeld, Germany), rabbit
anti-human aS1-casein (CSN1S1) was obtained from ModiQuest
(Nijmegen, The Netherlands), goat anti-rabbit IgG conjugated
with horseradish peroxidase was obtained from Sigma-Aldrich
(product number A0545 Munich, Germany) and goat anti-rabbit
IgG conjugated with FITC was obtained from Bethly (Montgom-
ery, USA). The restriction endonucleases were purchased from
New England Biolabs (Ipswich, MA, USA). 3,39,5,59tetramethyl-
benzidine (TMB) was obtained from Sigma-Aldrich (Munich,
Germany). MaxisorpH microplates were purchased from Nunc
(Langenselbold, Germany).
Bacterial strains and plasmids for CSN1S1 surface display
E. coli UT5600(DE3) [(F- ara14 leuB6 azi-6 lacY1 proC14 tsx-
67 entA403 trpE38 rfbD1 rpsL109 xyl-5 mtl-1 thi1, ompT-
fepC266)] [17] was used for the protein surface display. Plasmid
pHaS1C2 [18] was used for amplification of human CSN1S1 gene
without signal peptide by PCR. Plasmid pET Adx04, which
encodes the AIDA-I autotransporter and Adx04 as passenger, was
used for construction of the gene encoding the precursor protein
needed for the surface display of CSN1S1 [19]. The CSN1S1
encoding DNA fragment amplified by the primers RM001 [59-
GCC TCG AGA GGC CTA AAC TTC CTC TTA G -39] and
RM002 [59- CCG GTA CCC CAC TGT AGC ATG ACG -39]
was inserted by XhoI and KpnI restriction sites in plasmid pET
Adx04 [19] and yielded plasmid pKP10 (Fig. 1). This resulted in
an in frame fusion of the CSN1S1 encoding DNA region with the
gene needed for surface display in E. coli. For pre-absorption of
human sera, E. coli UT5600 (DE3) pET-SH3 [17] was used,
expressing all the domains needed for autodisplay except CSN1S1.
Bacteria were routinely grown at 37uC in Lysogeny-Broth (LB)
containing 50 mg/L of ampicillin with ethylenediaminetetraace-
tate (EDTA, final concentration 10 mM) and b-mercaptoethanol
(10 mM). SDS-PAGE, outer membrane protein preparation,
surface detection of CSN1S1 and flow cytometer analysis was
performed as described before [16].
Indirect immunofluorescence
E. coli cells were grown as described above. After induction of
protein expression, cells were labelled and fixed on a microscope
slide, sealed with a cover slip. Analysis followed by a ZeissH
microscope (Axioskop 2 plus) using an extinction at 490 nm and
emission at 515 nm.
SD-ELISA
The principle of the SD ELISA is shown in Fig. S1. After
induction of protein expression, E. coli cells were washed twice
with PBS (pH 7.4) and applied to the wells of 96 well microplates
Figure 1. Structure of the CSN1S1 fusion protein for SD ELISA development. The environment of the fusion sites is given as sequences. The
eight amino acids at the N-terminus and the two amino acids at the C-terminus that were added to CSN1S1 due to the cloning procedure are shown
in italics. Restriction sites used for cloning are underlined. SP, signal peptide.
doi:10.1371/journal.pone.0032716.g001
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(maxisorpH; Nunc, Langenselbold, Germany) in portions of 100 ml
(OD578 = 0.5). After incubation overnight at 37uC, a blocking step
followed with 150 ml PBS (pH 7.4)+10% FCS for 3 h at RT.
Subsequently, incubation with human sera (100 ml; 1:200) or – as
positive control - with a polyclonal rabbit anti-CSN1S1 serum
followed for 1 h at RT. Wells were washed 36 with PBS
(pH 7.4)+0.1% Tween 20. As next step, 100 ml of goat anti-human
IgG conjugated with horseradish peroxidase (HRP; 1:10,000 in
PBS with 10% FCS) was added. After 45 min at RT, wells were
washed 36 with PBS (pH 7.4)+0.1% Tween 20 and 100 ml of
3,39,5,59tetramethylbenzidine (TMB) was added. Incubation in
the dark at RT followed (25 min) and the reaction was stopped
with 100 ml 2 M H2SO4. A450 was measured with a microplate
reader (Berthold Technologies, Bad Wildbad, Germany).
Preabsorption of sera
E. coli UT5600(DE3) pET-SH3 was grown overnight (37uC,
200 rpm) and expression of the control protein was induced by
adding 1 mM IPTG for 60 min at 30uC and shaking (200 rpm).
Cells were harvested, washed once in PBS (pH 7.4) and suspended
to a final OD578 of 20 in PBS (pH 7.4). 145 ml of this solution was
mixed with 5 ml human serum incubated for 5 hours (37uC,
800 rpm) using a thermo shaker (Labnet Vortemp 56, Oakham,
UK). Subsequently, the supernatant was harvested, transferred to
reaction tube with the pellet of 145 ml bacterial cell solution
(OD=20) and incubated for another 15 h (37uC, 800 rpm).
Supernatant was harvested again and diluted with 850 ml PBS
(pH 7.4) containing 10% FCS, resulting in 1:200 final dilution of
the serum applied finally to the SD-ELISA.
Results
Autodisplay of aS1-casein (CSN1S1)
For SD-ELISA (surface display ELISA) in order to detect an
antibody reaction against CSN1S1, the human protein was
displayed on the surface of E. coli. This was facilitated by
Autodisplay, an efficient and convenient surface display system in
E. coli [20,21]. By similar means, an SD-ELISA for human Ro/
SS-A autoantigen has previously been established: Validation of
the assay on Ro/SS-A positive patients with systemic lupus
erythematosus and healthy volunteers resulted in a sensitivity and
selectivity that was at least identical, if not improved in comparison
to commercially available standard ELISA [16]. The advantage of
SD ELISA is that protein purification for coating the ELISA
microplate with the antigen is not necessary (see Fig. S1:
Schematic description of the SD-ELISA for CSN1S1 detection
in human sera). The microplates used in an SD ELISA are simply
coated by whole cells of E. coli displaying the target antigen. For
Autodisplay of human CSN1S1, the corresponding gene was
amplified by PCR and inserted into the plasmid pET Adx04 [19],
resulting in plasmid pKP010 (Fig. 1). Plasmid pKP10 directed the
expression of an artificial gene encoding a fusion protein
comprising a signal peptide at the very N-terminus, CSN1S1, a
linker domain and the b-barrel responsible for outer membrane
translocation. Plasmid pKP010 was transformed into E. coli
UT5600(DE3) and the expression of the CSN1S1 fusion protein
was analyzed by SDS-PAGE. For this purpose, outer membrane
proteins were prepared from E. coli UT5600(DE3) pKP010 cells
after protein expression induced by addition of 1 mM IPTG. E.
coli UT5600(DE3) cells without plasmid served as a negative
control. IPTG addition resulted in a further protein band
corresponding to the calculated size of the CSN1S1 fusion protein
(approximately 70 kDa). A band of similar size was not detectable
in control cells. This indicated that the CSN1S1 fusion protein was
expressed in the outer membrane of E. coli.
To find out whether human CSN1S1 was indeed displayed at
the cell surface, two different types of experiments were
performed. One option to prove the surface display of a protein
is to investigate its accessibility to proteases added from the
exterior. Proteases like trypsin are too large to cross the outer
membrane and only proteins displayed at the cell surface can be
digested. As seen in figure 2.1, lane 2, the 70 kDa band
representing the CSN1S1 fusion protein completely disappeared
after incubation with trypsin. In both samples natural outer
membrane proteins Omp F/C and OmpA remained unaffected.
Because OmpA has a periplasmic extension directed towards the
inner side of the outer membrane, this indicated that the cell
envelope remained intact during trypsin treatment.
To support this finding, E. coli cells displaying CSN1S1 were
subjected to indirect immunofluorescence using a polyclonal
rabbit serum against CSN1S1. Antibodies like proteases are too
large to be able to cross the outer membrane. As a consequence, in
case the rabbit antiserum detects the CSN1S1 domain, it must be
displayed at the cell surface. E. coli UT5600(DE3) pKP010 cells
and E. coli UT5600(DE3) cells as control were incubated with
rabbit anti-human CSN1S1 serum for 30 min at room temper-
ature. After repeated washing, incubation with a goat anti-rabbit
IgG conjugated to FITC followed and whole cell fluorescence was
analyzed by flow cytometry. As seen in Fig. 2.2, the mean
fluorescence (mF) of cells expressing the CSN1S1 fusion protein
(10,071) was 22 times as high as that of control cells (464), thus
indicating that the CSN1S1 domain was indeed accessible at the
cell surface. In addition, cells displaying human CSN1S1 were
labelled accordingly, but analyzed by immunofluorescence
microscopy. As shown in Fig. 2.3, again only cells displaying
CSN1S1 on the surface exhibited a green fluorescence, caused by
binding of the rabbit anti-CSN1S1 antibodies and a FITC labelled
secondary anti-rabbit IgG antibody.
SD-ELISA with sera of 62 healthy volunteers
For each patient serum to be tested, three wells of a 96 well plate
were coated with E. coli UT5600(DE3) pKP010 and additional
three wells were coated with E. coli UT5600(DE3) as a control. In
order to avoid effects caused by the host E. coli, and therefore
being independent of CSN1S1, the absorption values obtained
from the control E. coli UT5600(DE3) cells were subtracted from
the values obtained with E. coli displaying CSN1S1, as it has been
done before in the Ro/SS-A SD-ELISA [16]. The difference in
the mean of the absorption values measured for each cell type
were supposed to represent the serum reaction against mere
CSN1S1. As consequence, the absorption values obtained for each
serum were averaged and standard deviations were calculated.
Finally, 62 sera obtained from healthy volunteers were tested by
using this protocol. As summarized in Fig. 3, a remarkable
antibody reaction against CSN1S1 was detectable in 40 out of the
62 sera analyzed.
To analyze the hypothesis that a history of breast-feeding was
associated with the development of anti-CSN1S1 antibodies,
healthy donors were divided into two groups: a breast-fed and a
formula-fed consortium. This resulted in two clear cut and
significantly different populations and a cut-off analysis could be
performed. For each possible cut-off value, the sensitivity and
specificity was calculated by GraphPad PrismH [22,23]. These
values were plotted against the different cut-off values (Fig. 4A). In
the SD ELISA presented here, using cells of E. coli displaying
human CSN1S1 as an antigen source, a cut-off value of 0.4 was
defined (Fig. 4A) to distinguish positive from negative reactions. At
Breast-Feeding Induced CSN1S1-Autoantibodies
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Figure 2. Surface accessibility of human CSN1S1 on E. coli. 2.1) SDS-PAGE of outer membrane protein preparations from E. coli UT5600(DE3)
pKP010 which were incubated without trypsin (lane 1) and cells which were treated with trypsin (lane 2). OmpF/C and OmpA are natural outer
membrane proteins of E. coli, and can be used as reporters for successful outer membrane protein preparations. 2.2) Flow cytometer analysis of E. coli
cells displaying aS1-casein. (A) E. coli UT5600(DE3) pKP010 were incubated with a polyclonal rabbit antiserum against CSN1S1 casein and
subsequently with a secondary antibody conjugated with FITC. (B) The mean fluorescence of E. coli UT5600(DE3) pKP010 was 10,071. The value of the
fluorescence for E. coli UT5600(DE3) cells without a plasmid, used as a negative control, was 464. 2.3) Fluorescence microscopy of both cell types. The
cells were treated identically as described for flow cytometer analysis (2.2). (A) E. coli UT5600(DE3) pKP010 ; (B) E. coli UT5600(DE3) as negative control;
(C) E. coli UT5600(DE3) as negative control, transmission light control.
doi:10.1371/journal.pone.0032716.g002
Figure 3. Antibody reaction against human CSN1S1 in human sera. 62 sera of healthy volunteers were tested for antibodies against CSN1S1
with the SD-ELISA. Every serum was measured three times independently, the average was calculated and is shown as a column. SD of each mean is
given as a line.
doi:10.1371/journal.pone.0032716.g003
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this value, a maximum balance between sensitivity and specificity
was obtained. As a consequence, sensitivity had a value of 80%,
whereas specificity was 92%. In this case, the sera of the breast-fed
group had absorption values clearly over 0.5. As shown in Fig. 4B,
under these conditions, only 5 sera of the 25 donors, who were
formula-fed, showed an antibody reaction against CSN1S1
beyond the cut off, whereas 35 sera of the 37 donors, who where
breast-fed, reacted positive. There was no significant difference in
this antibody reaction with relation to sex or age of the healthy
donors analyzed (see Fig. S2: Comparing the serum reaction
against CSN1S1 of female and male test persons with respect to
being breast-fed as a neonates). Eight donors of the breast-fed
group were only breast-fed for a short term (from 5 days until 6
weeks). After this period of time, they were formula-fed. As shown
in Fig. 5, the limited duration of the breast-feeding period had no
influence on the strength of the serum reaction. This emphasized
the importance of breast-feeding as such for stimulating a serum
reaction against CSN1S1.
For cross checking, all sera were also investigated for antibodies
against Epstein-Barr virus (EBV) by a commercial ELISA, in order
to exclude that breast-feeding in general results in an enhanced
immune reaction. EBV was used because it is known, that almost
95% of all adult humans possess antibodies against the virus.
Accordingly, it was to expect that the majority of sera would react
on EBV. Our aim was to find out whether this reaction is
enhanced in persons being breast-fed, or whether there is an equal,
but random distribution in strength between sera from breast-fed
and non–breast fed persons. As can be seen in Fig. 6, there was no
significant difference in the strength of the serum reaction against
EBV between the two consortia, breast-fed and non-breast fed
(P= 0.213). The absorption values of both groups spread equally
between 60 and .750 U/ml. According to the manufacturers
recommendation, the cut-off value is 10 U/ml for this ELISA test
(against EBV virus capsid antigen, VCA). Accordingly, 60 out of
the 62 sera analyzed showed a serum reaction against EBV-VCA.
This represented 96% of all probands and corresponded to the
values reported before [24]. The two persons whose sera were
negative belonged to the group of breast-fed, a minor but further
hint, that breast-feeding does not lead to an enhanced immune
reaction in general.
Although medical records of all probands were negative for cow
milk allergy and there is only weak sequence homology between
human and bovine CSN1S1, with the exception of the first 20
amino acids, which belong to the signal peptide and which is
cleaved off at position 15/16 between A and R during transport
into the endoplasmatic reticulum (Fig. S3), it is important to
experimentally verify, that the detected IgG mediated response to
human CSN1S1 is not due to a cross-reactivity against the bovine
milk protein, to which all probands are likely to be exposed later in
life for most of their entire life span. In order to exclude such a
contribution of subsequent exposure to bovine CSN1S1 in the
Figure 4. Analyzing the serum reaction against human CSN1S1 with respect to formula-fed and breast-fed test persons. 4.1) For each
cut-off value, sensitivity and specificity were calculated to choose the optimal cut-off value for the assay which was 0.4. sensitivity; & specificity m
4.2) The 62 probands were divided into two collectives (formula-fed and breast-fed). 25 of the 62 volunteers were formula-fed and 37 were breast-fed.
Only 5 sera of the formula-fed collective have an absorption value over 0.4 and 2 sera of the breast-fed collective have an absorption value under 0.4.
(dotted line = cut-off value).
doi:10.1371/journal.pone.0032716.g004
Figure 5. Serum reaction against human CSN1S1 in probands
who were breast-fed for a short period of time. Eight probands
who were breast fed for a short period of time (5 d–42 d), showed an
increased antibody reaction against CSN1S1 in comparison to control
persons, who were not breast-fed. (dotted line = cut-off value from
Fig. 4).
doi:10.1371/journal.pone.0032716.g005
Figure 6. Serum reaction against EBV-VCA in formula-fed and
breast-fed probands analyzed as a control. A commercially
available ELISA for antibodies against EBV-VCA was used as described
in material and methods.
doi:10.1371/journal.pone.0032716.g006
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development and maintenance of anti-human CSN1S1 antibodies,
a similar SD-ELISA as described for human CSN1S1 was
developed for the bovine protein. For this purpose the bovine
CSN1S1 encoding DNA fragment was synthesized according to
the available sequence information in the Genbank database
(UniProt: P02662.2) with lateral restriction sites XhoI and KpnI
and inserted in the Autodisplay expression vector as described for
the human antigen (Fig. 1). Expression of the resulting fusion
protein was monitored by SDS-PAGE and surface display of the
bovine CSN1S1 domain was verified by a protease accessibility
assay and by indirect immunofluorescence. Subsequently the cells
displaying the bovine protein were used to analyze the serum
reaction of the probands against this antigen at the identical
conditions as described for the SD ELISA against human
CSN1S1. With the exception of two sera, corresponding to
sample no. 39 and sample no. 53 according to Fig. 3, none of the
sera analyzed exhibited a reaction against bovine CSN1S1. Both
samples no. 39 and no. 53 belonged to the group of formula-fed
persons, who turned out to be negative towards a reaction against
human CSN1S1. The reaction of the two sera was only weak
(0.076 for no. 39 and 0.362 for 53) and below the cut off value for
a positive reaction as determined for the human antigen. Hence,
there is no correlation between the reaction against human
CSN1S1 and bovine CSN1S1 in the analyzed human sera. These
data suggest that cross-reactivity of human and bovine CSN1S1
antibodies can be excluded to be responsible for the observed
effects.
For cross checking and in order to elucidate whether the SD
ELISA against bovine CSN1S1 can yield higher absorption values
in principle, a commercially available polyclonal rabbit antiserum
directed against bovine CSN1S1 was applied with a secondary
goat-anti rabbit IgG coupled with horseradish peroxidase. As can
be seen in Fig. 7A, this resulted in an absorption of beyond 0.7
when cells displaying bovine CSN1S1 were used to coat the
microplate well. In case controls cells of E. coli, or cells of E. coli
displaying human CSN1S1 were used, the absorption values
obtained were below 0.1. This again indicates that there is no cross
reactivity between human and bovine CSN1S1 and emphasizes
the negative results obtained with the human sera in the SD
ELISA with bovine CSN1S1. The reaction obtained with the
commercially available rabbit antiserum in the SD ELISA against
bovine CSN1S1 was concentration dependant (Fig. 7B) and
exhibited high reproducibility (Fig. 7C).
Although the antigenic stimulus from breast-feeding during
infancy would be expected to result in an IgG response rather than
an IgM response, a surface display ELISA for anti human
CSN1S1-IgM was developed in order to clarify if the serum
response induced by breast feeding is effecting IgG exclusively or
may also influences the IgM repertoire. The assay was performed
under identical conditions, but instead of goat anti-human IgG
conjugated with horseradish peroxidise, a goat anti-human IgM
conjugated with horseradish peroxidise was employed. As can be
seen in Fig. 8, which gives the difference in absorption between
cells displaying human CSN1S1 and the absorption values
obtained with control E. coli for each serum, the IgM mediated
response was much lower than the response mediated by IgGs.
Only insufficient amounts of serum no. 62 were available, and
therefore excluded from this part of the investigation. The mean
value of the reaction against control cells was 0.810 in case of the
IgG dependant SD ELISA, while the corresponding value for the
IgM dependant SD ELISA was 0.328, which appears to reflect the
generally lower presence of IgM antibodies in comparison to IgG
antibodies in human sera. Nevertheless, there were a few sera, that
exhibited a difference in absorption beyond 0.4, the cut-off value
Figure 7. Antibody reaction against bovine aS1-casein. (A)
Antibody reaction against E. coli UT5600(DE3) pSH3 (control, lane1), E.
coli UT5600(DE3) displaying human CSN1S1 (lane 2) and E. coli
UT5600(DE3) displaying bovine CSN1S1 (lane3) measured by SD-ELISA
with a rabbit polyclonal anti- bovine CSN1S1 antibody. For detection a
goat HRP conjugated anti rabbit antibody was used according to the
conditions described for Fig. 3. (B) The antibody reaction against E. coli
UT5600(DE3) pSH3 (control, black columns) and E. coli UT5600(DE3)
displaying bovine CSN1S1 (white columns) were analyzed at different
concentrations of the rabbit polyclonal anti-bovine CSN1S1 antiserum
or in PBS with 3% FCS as negative control. (C) The SD ELISA against
bovine CSN1S1 was repeated three times independently in triplicates at
the highest antibody concentration applied (200 ng/ml) with E. coli
UT5600(DE3)SH3 (control, lanes 1–3) and E. coli UT5600(DE3) displaying
bovine CSN1S1 (lane4–6) in order to test the reproducibility.
doi:10.1371/journal.pone.0032716.g007
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determined in the IgG SD ELISA. However, there were no
differences in IgM-responses between the breast-fed and formula-
fed group. (Fig. 9). The mean value in case of the breast fed
consortium was 0.174, whereas the mean value obtained with the
formula fed consortium was 0.259. According to a one way
analysis of variance (ANOVA) with subsequent Sheffe´-test using
WinStat. Version 2007.1, the mean values are not significantly
different (P=0.05).
Discussion
In the present study, we analyzed whether there is a serum
reaction against human aS1-casein (CSN1S1) in humans.
Moreover, because CSN1S1 is a major component of breast milk,
we investigated whether there is a difference in serum reaction
concerning breast-feeding. 62 sera were analyzed with an SD
ELISA as described before for Ro/SS-A [16]. At first sight, it
clearly turned out that there is a significant reaction against
CSN1S1 in human sera. The healthy donors were divided into two
groups, a breast-fed (37 donors) and a formula-fed group (25
donors). Examining single absorption values revealed an average
value of 0.432+/2SD for the formula-fed group and 0.894+/
2SD for the breast-fed group. This difference was statistically
significant in Mann-Whitney U-Test (P = 0.002). Interestingly, it
appeared that the length of breast-feeding has no influence on the
antibody reaction. The serum of a person who stated to have been
breast-fed for only one week exhibited the highest serum reaction
against CSN1S1 among the short time breast-fed persons (Fig. 5).
This is notable because the immune system of neonates is assumed
to be incompletely developed [25,26]. During pregnancy, the fetus
obtains maternal IgGs via the placenta. As we analyzed sera of
adults, this cannot account for the serum reactions observed. It
rather appears that this immune response was acquired during
breast-feeding and it cannot be excluded that this has happened
during the earliest days of infancy.
There are reports suggesting that breast-feeding leads to an
improved development of the immune system in infants
[27,28,29]. For example, breast-fed children have a higher serum
antibody-titer against Haemophilus influenzae type b [29] or
diphtheria toxin [28] after vaccination. Thus, we had to exclude
that breast-feeding leads to a stronger immune response in general,
thereby accounting for higher CSN1S1-Ab titers in breast-fed
individuals. This could be excluded by the example of equal serum
reaction against EBV-VCA in both groups. EBV was used because
nearly 95% of the adult population has antibodies against EBV-
VCA, but in most if not all cases due to a contact in later life time.
This notion is not necessarily contradicted by the above mentioned
findings of higher antibody-titers of breast-fed children after
Haemophilus influenzae type b or diphtheria toxin immunization.
Indeed, based on the present results, one could raise the hypothesis
that breast-feeding enhances the immune reaction of infants or
new born, but this effect is lost or overlaid at later life time, a
hypothesis of course, that needs further investigation.
Figure 8. IgM reaction against human CSN1S1 in human sera. 61 of the 62 sera shown in Fig. 3 with the IgG reaction on human CSN1S1 were
analyzed for an IgM mediated serum response on the same antigen by SD-ELISA. Each serum was tested three times, the mean was calculated and
shown as columns. SD of each mean is given as a line.
doi:10.1371/journal.pone.0032716.g008
Figure 9. Analyzing the IgM serum reaction against human
CSN1S1 with respect to formula-fed and breast-fed test
persons. 61 of the 62 sera shown in Fig. 3 were divided into two
consortia, a formula-fed and breast-fed, as it is shown for the IgG
mediated response in Fig. 4. The formula-fed consortium comprises the
sera of 25 volunteers, whereas within the breast-fed consortium 36 sera
were analyzed.
doi:10.1371/journal.pone.0032716.g009
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At this point the question arises whether the enhanced serum
reaction against CSN1S1 may be related to the wide-spread cow
milk allergy (CMA). Bovine CSN1S1 is the main allergen in CMA,
but in over 60% of all cases, this reaction is mediated by IgE
antibodies [30]. In the present investigation, the serum reaction
can clearly be assigned to IgGs. In addition to the IgE mediated
immune reaction, 89% of all CMA patients exhibit an IgG
mediated immune reaction against bovine CSN1S1. The domain
targeted by these IgG antibodies was determined and found to be
located between amino acids 15 to 36 of bovine CSN1S1 [31]. For
this domain of bovine CSN1S1, however, there is no homologous
domain existing in human CSN1S1 and therefore, a cross
reactivity of IgG antibodies directed against bovine CSN1S1 with
human CSN1S1 can be excluded (see Fig. S3: Amino acid
sequence alignment of bovine and human aS1-casein (CSN1S1)
using the Smith and Waterman algorithm). Finally, none of the
persons whose sera were analyzed on an immune reaction against
human CSN1S1 in the present study, reported averse reactions to
cow-milk, suggesting CMA. In accordance with this, cross-
reactivity of human CSN1S1 antibodies to bovine CSN1S1 could
be excluded in the cohort by a novel SD ELISA for the bovine
molecule.
It is notable that the strong IgG mediated immune reaction
against human CSN1S1 in the sera of adults is obviously caused by
breast-feeding, or in other words, by an oral application of the
antigen during infancy. Well-known examples of oral vaccination
in humans include immunization against polio and rotavirus. But
in both cases, the immune response is raised against an – from an
evolutionary point of view - old human pathogen, and it appears
reasonable that any contact, even oral application, leads to a
strong and sustaining immune response. Oral immunization is
used in chicken for subsequent harvesting of antigen specific
polyclonal antibodies from egg yolk. But in this case again, the
antigens applied are no self-proteins but foreign antigens [32].
This is also true for the striking increased amount of IgG
antibodies against food antigens in the jejunal perfusion fluid of
rheumatoid arthritis patients when compared to healthy control
persons [33]. To our knowledge, the data presented here for
human CSN1S1 are the first example that oral application of a
self-protein in earliest childhood leads to a strong IgG mediated
immune response that is sustained into adulthood. While breast-
fed induced reaction against CSN1S1 is clearly based on an IgG
rather than an IgM response, we strikingly detected anti human
CSN1S1-IgM antibodies (albeit in low concentrations) in both
nursed and formula-fed individuals without any difference. This
might suggest a more recent antigenic stimulus. It has recently
been shown, that human CSN1S1 is expressed in human
monocytes and induces pro-inflammatory cytokines [15]. Such
ectopic expression of CSN1S1 could potentially be an explanation
for the IgM mediated reaction on human CSN1S1 observed in the
corresponding SD ELISA for a few sera. However, further
systematic and thorough investigations will be required before
such a relationship can be postulated.
It has been known for a long time that orally administered
antigens can induce immune tolerance, when the same antigen
was used in a further challenge. Therefore, oral tolerance has been
employed for the treatment of human autoimmune diseases such
as rheumatoid arthritis and multiple sclerosis [34]. In contrast,
however, it was shown more recently that oral application of an
autoantigen, in particular ovalbumin, can lead to a strong immune
response in a corresponding mouse model [35] and finally was
found to induce autoimmune diabetes [36]. The only general
conclusion that can be drawn from summarizing these reports is
that orally administered autoantigens can influence the peripheral
immune system via the gut, either in a tolerance inducing or a
stimulating manner. One could speculate about a possible role of
human CSN1S1 in this context. Very recently we provided
evidence that human CSN1S1 has an immunomodulatory
function, that it is expressed by human monocytes and stimulates
the expression of pro-inflammatory cytokine GM-CSF [8]. In the
present study, we were able to show that human CSN1S1 induces
a sustained IgG serum reaction in adults when applied orally
during early infant development. This clearly indicates a task
beyond its nutritional function in milk and could point on a more
general role of human CSN1S1 during immune system develop-
ment, e.g. in an early onset of the adaptive immune response, a
hypothesis, of course, that needs further investigation.
The advantage of the SD ELISA presented here by application
of the Autodisplay technology is that ELISAs for antibody-testing
can be generated for a wide variety of antigens very rapidly and
directly by expression on E. coli, Some disadvantage might be that
- despite repeated stripping of the sera to be analyzed with control
cells of E. coli – detectable amounts of antibodies directed against
the host cell remain left. Therefore, serial dilutions in order to
obtain exact antibody titers are not possible, and in addition, the
control values obtained by analyzing the serum response against
control cells of E. coli without antigen are usually exceeding zero.
However, in such a scenario, it is very important to have a look on
the absolute values obtained with controls cells and control,
whether these values are significantly different (or not) from those
obtained with cells displaying the antigen. In the present study, the
mean of the values obtained with control cells in the breast fed
consortium was 0.778, whereas the same mean in the formula fed
consortium was 0.854. Both values turned out to be not
significantly different. In contrast, the values obtained with
CSN1S1 displaying cells in the breast fed consortium was 1.664,
whereas the same mean in the formula fed consortium was 1.350.
The means obtained with controls cells and with CSN1S1
displaying cells for both consortia were analyzed by one-way
analysis of variance (ANOVA) with subsequent Sheffe´-test using
WinStat. version 2007.1 and it turned out, that both means in the
breast fed consortium were significantly different, whereas in the
formula fed group, both means were not significantly different
(P=0.001). This result was supported by applying a separate t-test
for each serum in the breast fed consortium, comparing the mean
values obtained with CSN1S1 displaying cells with those obtained
with control cells. For all 35 sera, that showed a reaction beyond
the cut off values of 0.4, the mean values were significantly
different (P=0.001), whereas for the sera, showing a reaction
below the cut off value they were not significantly different.
In conclusion, we showed that there is an autoimmune reaction
against human CSN1S1 and this autoimmune reaction in adults is
orally determined by breast-feeding.
Supporting Information
Figure S1 Schematic description of the SD-ELISA for
CSN1S1 detection in human sera. (A) After induction of
protein expression, cells of E. coli displaying the antigen – in the
present study CSN1S1 – are used for coating the wells of a 96 well
microplate overnight. After washing with PBS containing 0.1%
tween, the sera to be tested on a reaction against the surface
displayed antigen were applied for 1 h (B). Before application, the
sera were stripped twice with cells of E. coli without the surface
displayed antigen in order to remove the serum antibodies directed
against the gram negative bacteria but not against CNS1N1. (C)
After washing again with PBS containing 0.1% tween, a secondary
antibody – goat anti-human IgG conjugated with horse radish
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peroxidase (HRP) is added. (D) The HRP substrate 3,39,5,59tetra-
methylbenzidine (TMB) is added and concentration of serum
antibodies against CSN1S1 is quantified by measuring the
absorption at 450 nm. For each serum to be analyzed three wells
are treated identically and mean values and standard deviations
are determined, as well as three wells are coated with E. coli
without CSN1S1 and incubated with the same serum as control.
The mean value obtained with the control was substracted from
the mean value obtained with CSN1S1 displaying cells in order to
minimize background absorption.
(PPT)
Figure S2 Comparing the serum reaction against
CSN1S1 of female and male test persons with respect
to being breast-fed as a neonates.
(PPT)
Figure S3 Amino acid sequence alignment of bovine and
human aS1-casein (CSN1S1) using the Smith and
Waterman algorithm. Amino acids (aa) are given in the one
letter code. The region identified in 89% of patients suffering from
cow milk allergy (CMA) by an overlapping dodecapeptide dot blot
approach to be targeted by IgG antibodies (reference 31) is
underlayed in green. Remarkably, the 93% identity observed
between the bovine and the human protein within the first 15 aa
belong to the signal peptide, which is supposed to be cleaved
between a-l-a and r (between aa 15 and 16) after membrane
transport.
(PPT)
Author Contributions
Conceived and designed the experiments: JJ KP SV MS. Performed the
experiments: KP RM AB EB TS. Analyzed the data: KP SV JJ MS AB.
Wrote the paper: JJ SV KP. Graphs: AB.
References
1. Silverstein AM, Lukes RJ, Kraner KL, Uhr JW (1963) Fetal response to
antigenic stimulus .2. Antibody production by fetal lamb. J Exp Med 117:
799–&.
2. van Furth R, Schuit HR, Hijmans W (1965) The immunological development of
the human fetus. J Exp Med 122: 1173–1188.
3. Rejnek J, Prokesova L, Travnicek J (1974) Early antibodies to human serum
albumin formed in germfree piglets. Folia Microbiol (Praha) 19: 520–524.
4. Chucri TM, Monteiro JM, Lima AR, Salvadori MLB, Kfoury JR, et al. (2010) A
review of immune transfer by the placenta. Journal of Reproductive
Immunology 87: 14–20.
5. Vidor E (2007) Vaccination of newborns against hepatitis a in the presence of
maternally derived antibodies (2007). J Comp Pathol 137 Suppl 1: S42–45.
6. Wilson CB, Kollmann TR (2008) Induction of antigen-specific immunity in
human neonates and infants. Nestle Nutr Workshop Ser Pediatr Program 61:
183–195.
7. Merbl Y, Zucker-Toledano M, Quintana FJ, Cohen IR (2007) Newborn
humans manifest autoantibodies to defined self molecules detected by antigen
microarray informatics. J Clin Invest 117: 712–718.
8. Barbouche R, Forveille M, Fischer A, Avrameas S, Durandy A (1992)
Spontaneous igm autoantibody production invitro by lymphocytes-b of normal
human neonates. Scand J Immunol 35: 659–667.
9. Meffre E, Salmon JE (2007) Autoantibody selection and production in early
human life. J Clin Invest 117: 598–601.
10. Kapogiannis BG, Gussin HA, Teodorescu M (2001) De novo production of igg
antinuclear antibodies in a neonate. J Rheumatol 28: 2744–2747.
11. Jenness R, Holt C (1987) Casein and lactose concentrations in milk of 31 species
are negatively correlated. Experientia 43: 1015–1018.
12. Mercier JC, Vilotte JL (1993) Structure and function of milk protein genes.
J Dairy Sci 76: 3079–3098.
13. Miller MJ, Witherly SA, Clark DA (1990) Casein: A milk protein with diverse
biologic consequences. Proc Soc Exp Biol Med 195: 143–159.
14. Franco OL (2011) Peptide promiscuity: An evolutionary concept for plant
defense. FEBS Lett 585: 995–1000.
15. Vordenbaumen S, Braukmann A, Petermann K, Scharf A, Bleck E, et al. (2011)
Casein alpha s1 is expressed by human monocytes and upregulates the
production of gm-csf via p38 mapk. J Immunol 186: 592–601.
16. Petermann K, Vordenbaumen S, Pyun JC, Braukmann A, Bleck E, et al. (2010)
Autodisplay of 60-kda ro/ss-a antigen and development of a surface display
enzyme-linked immunosorbent assay for systemic lupus erythematosus patient
sera screening. Anal Biochem 407: 72–78.
17. Jose J, Handel S (2003) Monitoring the cellular surface display of recombinant
proteins by cysteine labeling and flow cytometry. Chembiochem 4: 396–405.
18. Kim TR, Goto Y, Hirota N, Kuwata K, Denton H, et al. (1997) High-level
expression of bovine beta-lactoglobulin in pichia pastoris and characterization of
its physical properties. Protein Eng 10: 1339–1345.
19. Jose J, Bernhardt R, Hannemann F (2002) Cellular surface display of dimeric
adx and whole cell p450-mediated steroid synthesis on e. Coli. J Biotechnol 95:
257–268.
20. Jose J (2006) Autodisplay: Efficient bacterial surface display of recombinant
proteins. Appl Microbiol Biotechnol 69: 607–614.
21. Jose J, Meyer TF (2007) The autodisplay story, from discovery to biotechnical
and biomedical applications. Microbiol Mol Biol Rev 71: 600–619.
22. Greiner M, Sohr D, Gobel P (1995) A modified roc analysis for the selection of
cut-off values and the definition of intermediate results of serodiagnostic tests.
J Immunol Methods 185: 123–132.
23. Zou KH, O’Malley AJ, Mauri L (2007) Receiver-operating characteristic
analysis for evaluating diagnostic tests and predictive models. Circulation 115:
654–657.
24. Wang X, Yang K, Wei C, Huang Y, Zhao D (2010) Coinfection with ebv/cmv
and other respiratory agents in children with suspected infectious mononucle-
osis. Virol J 7: 247.
25. Hayward AR (1983) The human fetus and newborn: Development of the
immune response. Birth Defects Orig Artic Ser 19: 289–294.
26. Lawton AR (1999) Igg subclass deficiency and the day-care generation. Pediatr
Infect Dis J 18: 462–466.
27. Carver JD, Pimentel B, Cox WI, Barness LA (1991) Dietary nucleotide effects
upon immune function in infants. Pediatrics 88: 359–363.
28. Hahn-Zoric M, Fulconis F, Minoli I, Moro G, Carlsson B, et al. (1990) Antibody
responses to parenteral and oral vaccines are impaired by conventional and low
protein formulas as compared to breast-feeding. Acta Paediatr Scand 79:
1137–1142.
29. Pabst HF, Spady DW (1990) Effect of breast-feeding on antibody response to
conjugate vaccine. Lancet 336: 269–270.
30. Sampson HA (1999) Food allergy. Part 1: Immunopathogenesis and clinical
disorders. J Allergy Clin Immunol 103: 717–728.
31. Chatchatee P, Jarvinen KM, Bardina L, Beyer K, Sampson HA (2001)
Identification of ige- and igg-binding epitopes on alpha(s1)-casein: Differences in
patients with persistent and transient cow’s milk allergy. J Allergy Clin Immunol
107: 379–383.
32. Hau J, Hendriksen CF (2005) Refinement of polyclonal antibody production by
combining oral immunization of chickens with harvest of antibodies from the
egg yolk. ILAR J 46: 294–299.
33. Hvatum M, Kanerud L, Hallgren R, Brandtzaeg P (2006) The gut-joint axis:
Cross reactive food antibodies in rheumatoid arthritis. Gut 55: 1240–1247.
34. Weiner HL, Friedman A, Miller A, Khoury SJ, al-Sabbagh A, et al. (1994) Oral
tolerance: Immunologic mechanisms and treatment of animal and human
organ-specific autoimmune diseases by oral administration of autoantigens.
Annu Rev Immunol 12: 809–837.
35. Blanas E, Heath WR (1999) Oral administration of antigen can lead to the onset
of autoimmune disease. Int Rev Immunol 18: 217–228.
36. Blanas E, Carbone FR, Allison J, Miller JF, Heath WR (1996) Induction of
autoimmune diabetes by oral administration of autoantigen. Science 274:
1707–1709.
Breast-Feeding Induced CSN1S1-Autoantibodies
PLoS ONE | www.plosone.org 9 April 2012 | Volume 7 | Issue 4 | e32716
